Cost utility analysis of immunosuppressive regimens in adult renal transplant recipients in England and Wales

BACKGROUND: End-stage renal disease is the irreversible final stage of chronic kidney disease and is fatal when not managed by either transplantation or dialysis. Transplantation is generally preferred over dialysis. However, to prevent graft rejection or loss, lifelong immunosuppression is required...

Descripción completa

Detalles Bibliográficos
Autores principales: Muduma, Gorden, Shaw, Jane, Hart, Warren M, Odeyemi, Abayomi, Odeyemi, Isaac
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2014
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4226454/
https://www.ncbi.nlm.nih.gov/pubmed/25395839
http://dx.doi.org/10.2147/PPA.S69461

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4226454/
https://www.ncbi.nlm.nih.gov/pubmed/25395839
http://dx.doi.org/10.2147/PPA.S69461

Ejemplares similares